Jump Financial’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Sell
12,631
-5,686
-31% -$569K 0.02% 846
2025
Q4
$1.78M Buy
18,317
+11,217
+158% +$962K 0.02% 727
2025
Q3
$505K Buy
7,100
+2,881
+68% +$192K 0.01% 1270
2025
Q2
$252K Sell
4,219
-81
-2% -$4.44K ﹤0.01% 1486
2025
Q1
$226K Buy
4,300
+200
+5% +$11.2K ﹤0.01% 1382
2024
Q4
$226K Sell
4,100
-2,700
-40% -$142K ﹤0.01% 1440
2024
Q3
$342K Buy
6,800
+1,806
+36% +$83.3K 0.01% 1250
2024
Q2
$219K Sell
4,994
-532
-10% -$22.6K ﹤0.01% 1524
2024
Q1
$243K Buy
+5,526
New +$244K 0.01% 1564
2023
Q4
Sell
-4,600
Closed -$204K 1987
2023
Q3
$204K Sell
4,600
-3,774
-45% -$175K 0.01% 1510
2023
Q2
$400K Sell
8,374
-630
-7% -$28.4K 0.01% 1144
2023
Q1
$354K Buy
+9,004
New +$327K 0.01% 1041
2022
Q2
Sell
-11,500
Closed -$515K 1809
2022
Q1
$515K Buy
11,500
+6,100
+113% +$282K 0.02% 799
2021
Q4
$250K Buy
+5,400
New +$218K 0.02% 991

Other funds holding IRMD

Jump Financial's IRMD Position: Q1 2026 in Review

Jump Financial reduced its iRadimed (IRMD) stake by 31% in Q1 2026, selling an estimated $569K and leaving 12,631 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #846.

Jump Financial first reported a position in IRMD in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.78M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Jump Financial held 12,631 shares of iRadimed worth $1.22M as of Q1 2026.
  • Jump Financial sold 5,686 iRadimed shares in Q1 2026, an estimated $569K.
  • iRadimed made up 0.02% of Jump Financial's portfolio in Q1 2026, its #846 holding.
  • Jump Financial first reported a position in iRadimed in Q4 2021 and has held it in 14 quarters since.
  • Jump Financial's iRadimed position peaked at $1.78M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.